These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8165178)

  • 1. Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats.
    Zioncheck TF; Chen SA; Richardson L; Mora-Worms M; Lucas C; Lewis D; Green JD; Mordenti J
    Pharm Res; 1994 Feb; 11(2):213-20. PubMed ID: 8165178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing.
    Beck LS; DeGuzman L; Lee WP; Xu Y; Siegel MW; Amento EP
    J Clin Invest; 1993 Dec; 92(6):2841-9. PubMed ID: 8254038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats.
    Zioncheck TF; Richardson L; DeGuzman GG; Modi NB; Hansen SE; Godowski PJ
    Endocrinology; 1994 Apr; 134(4):1879-87. PubMed ID: 8137756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of radioiodinated recombinant human TGF-beta 1 binding to bone matrix within rabbit skull defects.
    Richardson L; Zioncheck TF; Amento EP; Deguzman L; Lee WP; Xu Y; Beck LS
    J Bone Miner Res; 1993 Nov; 8(11):1407-14. PubMed ID: 8266832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhancement in wound healing by transforming growth factor-beta 1 (TGF-beta 1) depends on the topical delivery system.
    Puolakkainen PA; Twardzik DR; Ranchalis JE; Pankey SC; Reed MJ; Gombotz WR
    J Surg Res; 1995 Mar; 58(3):321-9. PubMed ID: 7885030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant transforming growth factor-beta 1 modulation of biochemical and cellular events in healing of ulcer wounds.
    Chen TL; Bates RL; Xu Y; Ammann AJ; Beck LS
    J Invest Dermatol; 1992 Apr; 98(4):428-35. PubMed ID: 1548427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human transforming growth factor-beta 1 (rhTGF-beta 1) enhances healing and strength of granulation skin wounds.
    Beck LS; Chen TL; Mikalauski P; Ammann AJ
    Growth Factors; 1990; 3(4):267-75. PubMed ID: 2257148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topical rh-TGF-beta 1 on second intention wound healing in horses.
    Steel CM; Robertson ID; Thomas J; Yovich JV
    Aust Vet J; 1999 Nov; 77(11):734-7. PubMed ID: 10685169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of the intravenously administered recombinant human basic fibroblast growth factor, trafermin, in liver and kidney: degradation implicated in its selective localization to the fenestrated type microvasculatures.
    Yuge T; Furukawa A; Nakamura K; Nagashima Y; Shinozaki K; Nakamura T; Kimura R
    Biol Pharm Bull; 1997 Jul; 20(7):786-93. PubMed ID: 9255421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.
    Wakefield LM; Winokur TS; Hollands RS; Christopherson K; Levinson AD; Sporn MB
    J Clin Invest; 1990 Dec; 86(6):1976-84. PubMed ID: 2254455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short-term effects of repetitive E. coli-derived rhBMP-2 administration through intravenous injection in rats.
    Lee JH; Lee EN; Nam SH
    Drug Chem Toxicol; 2014 Jan; 37(1):40-7. PubMed ID: 23841455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant transforming growth factor-beta 1 in healing of calvarial bone defects.
    Bosch C; Melsen B; Gibbons R; Vargervik K
    J Craniofac Surg; 1996 Jul; 7(4):300-10. PubMed ID: 9133837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-beta 1.
    Beck LS; Chen TL; Hirabayashi SE; Deguzman L; Lee WP; McFatridge LL; Xu Y; Bates RL; Ammann AJ
    Growth Factors; 1990; 2(4):273-82. PubMed ID: 2337473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
    Ferraiolo BL; Moore JA; Crase D; Gribling P; Wilking H; Baughman RA
    Drug Metab Dispos; 1988; 16(2):270-5. PubMed ID: 2898346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of TGF-beta2 in various vehicles on incisional wound healing.
    Wright TE; Hill DP; Ko F; Soler PM; Smith PD; Franz M; Nichols EH; Robson MC
    Int J Surg Investig; 2000; 2(2):133-43. PubMed ID: 12678511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human transforming growth factor beta 3 accelerates gastric ulcer healing in rats.
    Coerper S; Sigloch E; Cox D; Starlinger M; Köveker G; Becker HD
    Scand J Gastroenterol; 1997 Oct; 32(10):985-90. PubMed ID: 9361170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of metabolically labeled recombinant soluble CD4 (sT4) in male Sprague-Dawley rats following intravenous and subcutaneous administration.
    Davis CB; Boyle KE; Urbanski JJ; Paradysz RT; Fong KL
    Drug Metab Dispos; 1992; 20(5):695-705. PubMed ID: 1358574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factors and bone regeneration. Implications of barrier membranes.
    Zellin G
    Swed Dent J Suppl; 1998; 129():7-65. PubMed ID: 9672999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler.
    Ongpipattanakul B; Nguyen T; Zioncheck TF; Wong R; Osaka G; DeGuzman L; Lee WP; Beck LS
    J Biomed Mater Res; 1997 Sep; 36(3):295-305. PubMed ID: 9260100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.